Please click on the relevant link for the information you require
All content is applicable to NHS South West London and SWL Providers (including Acute Trusts, Mental Health Trust and Community Services providers).
Rhinitis management: London regional guideline and pathway (New April 2025)
This is a pan London guideline for the diagnosis and treatment of rhinitis.
Headache: Referral and Management pathways for adults (New April 2025)
This guideline is aimed at primary care clinicians in NHS SWL. It outlines the headache referral and management pathway for adults (18 years or older) and signposts to national and local guidance where appropriate.
Migraine (Acute)
This guideline is intended for use by clinicians in primary care for the acute treatment of migraine in adults (age 18 years and above)
Melatonin prescribing guidance (New March 2025)
The melatonin prescribing guidance for children and young adults replaces the ‘melatonin – sleep disorders in children and adolescents’ shared care agreement. However, children and adolescents who have been treated in accordance with the previous shared care i.e. melatonin modified release tablets (Circadin), will continue with their treatment. At their next review with the specialist, the treatment will be reviewed and changed, where clinically appropriate to an approved licensed formulation in line with SWL formulary
Safe use of Valproate Policy (New March 2025)
The safe use of valproate policy provides advice and guidance for healthcare professionals to ensure the safe prescribing and dispensing of valproate for all patients across SWL. The policy must be used in conjunction with local standard operating procedures, organisational policies and the Medicines and Healthcare products Regulatory Agency (MHRA) Healthcare Professional Guide.‘Valproate’ is used to mean oral sodium valproate, valproic acid and valproate semi sodium.
Chronic Kidney Disease (CKD)
- Investigation and management of CKD is adults in primary care (updated)
- Sodium glucose co-transporter-2 inhibitors (SGLT2i) for treating CKD (updated)
- Finerenone for treating CKD (New)
COPD guidance (Updated November 2024)
Updated guidance on the management of chronic obstructive pulmonary disease (COPD), including a visual summary.
